Outcome | Trials | Participants | Effect size (95% CI) | Heterogeneity: I 2 ;Chi2 (p value) | Follow-up (months post-treatment ) | GRADE confidence rating |
---|---|---|---|---|---|---|
Peer support | 4 | 1723 | Â | Â | Â | Â |
Hospitalisation | 0 | N/A | N/A | N/A | N/A | N/A |
Symptoms of psychosis [45] | 1 | 448 | SMD = -0.00 (-0.19, 0.18) | N/A | 6 | Low 4,5 |
Employment | 0 | N/A | N/A | N/A | N/A | N/A |
2 | 639 | SMD = -0.24 (-0.40, -0.08) | 0%; 0.00 (p = 0.98) | 3-6 | Very low1, 4, 5 | |
2 | 721 | SMD = -0.17 (-0.32, -0.03) | 0%; 0.15 (p = 0.70) | 6 | Low4,5 | |
Overall psychiatric symptoms [45] | 1 | 448 | SMD = -0.08 (-0.26, 0.11) | N/A | 6 | Low4,5 |
2 | 757 | SMD = -0.23 (-0.37, -0.09) | 0%, 0.71 (p = 0.40) | 6 | Low4,5 | |
3 | 967 | SMD = -0.24 (-0.46, -0.02) | 65%; 5.74 (p = 0.06) | 3-6 | Very low1,2,4,5 | |
2 | 538 | SMD = -0.25 (-0.43, -0.07) | 12%; 1.13 (p = 0.29) | 6 | Very low1,4,5 | |
Satisfaction | 0 | N/A | N/A | N/A | N/A | N/A |